Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Schafer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hepatology (Baltimore, Md.)|April 9, 2008
Chronic genotype 4 hepatitis CDaniel F Schafer
Lancet (London, England)|October 22, 2002
Optimising immunosuppressionDaniel F Schafer, Michael F Sorrell
Journal of Global Health|January 5, 2013
A prescription for health inequity: Building public health infrastructure in resource-poor settingsAsad Moten, Daniel F Schafer, Elizabeth Montgomery
The American Journal of Gastroenterology|August 23, 2002
Severe cholestasis in a patient with acute hepatitis C treated with interferon alpha-2bSandeep Mukherjee, Richard K Gilroy, Daniel F Schafer
Journal of Gastroenterology and Hepatology|February 3, 2005
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patientsSandeep Mukherjee, Elizabeth Lyden, Timothy M McCashland, et al.
ACG Case Reports Journal|July 10, 2015
True versus Pseudo-Intestinal Malrotation: Case Series and ReviewHarshit S Khara, Shivangi T Kothari, Claudia B Gruss, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation DatabaseVijayan Balan, Kris Ruppert, A Jake Demetris, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|April 9, 2008
Chronic genotype 4 hepatitis CDaniel F Schafer
Lancet (London, England)|October 22, 2002
Optimising immunosuppressionDaniel F Schafer, Michael F Sorrell
Journal of Global Health|January 5, 2013
A prescription for health inequity: Building public health infrastructure in resource-poor settingsAsad Moten, Daniel F Schafer, Elizabeth Montgomery
The American Journal of Gastroenterology|August 23, 2002
Severe cholestasis in a patient with acute hepatitis C treated with interferon alpha-2bSandeep Mukherjee, Richard K Gilroy, Daniel F Schafer
Journal of Gastroenterology and Hepatology|February 3, 2005
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patientsSandeep Mukherjee, Elizabeth Lyden, Timothy M McCashland, et al.
ACG Case Reports Journal|July 10, 2015
True versus Pseudo-Intestinal Malrotation: Case Series and ReviewHarshit S Khara, Shivangi T Kothari, Claudia B Gruss, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation DatabaseVijayan Balan, Kris Ruppert, A Jake Demetris, et al.
Pageof 1